Global Point-of-Care Testing (POCT) Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

According to APO Research, The global Point-of-Care Testing (POCT) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Point-of-Care Testing (POCT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Point-of-Care Testing (POCT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Point-of-Care Testing (POCT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Point-of-Care Testing (POCT) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Point-of-Care Testing (POCT) include Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Point-of-Care Testing (POCT), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Point-of-Care Testing (POCT), also provides the sales of main regions and countries. Of the upcoming market potential for Point-of-Care Testing (POCT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Point-of-Care Testing (POCT) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Point-of-Care Testing (POCT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Point-of-Care Testing (POCT) sales, projected growth trends, production technology, application and end-user industry.

Point-of-Care Testing (POCT) Segment by Company

Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann

Point-of-Care Testing (POCT) Segment by Type

Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing

Point-of-Care Testing (POCT) Segment by Application

Clinics
Hospitals
Laboratory
Others

Point-of-Care Testing (POCT) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Point-of-Care Testing (POCT) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Point-of-Care Testing (POCT) Market Size, 2020 VS 2024 VS 2031
1.3 Global Point-of-Care Testing (POCT) Market Size Estimates and Forecasts (2020-2031)
1.4 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts (2020-2031)
1.5 Global Point-of-Care Testing (POCT) Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Point-of-Care Testing (POCT) Market Dynamics
2.1 Point-of-Care Testing (POCT) Industry Trends
2.2 Point-of-Care Testing (POCT) Industry Drivers
2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
2.4 Point-of-Care Testing (POCT) Industry Restraints
3 Point-of-Care Testing (POCT) Market by Manufacturers
3.1 Global Point-of-Care Testing (POCT) Revenue by Manufacturers (2020-2025)
3.2 Global Point-of-Care Testing (POCT) Sales by Manufacturers (2020-2025)
3.3 Global Point-of-Care Testing (POCT) Average Sales Price by Manufacturers (2020-2025)
3.4 Global Point-of-Care Testing (POCT) Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Point-of-Care Testing (POCT) Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Point-of-Care Testing (POCT) Manufacturers, Product Type & Application
3.7 Global Point-of-Care Testing (POCT) Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Point-of-Care Testing (POCT) Players Market Share by Revenue in 2024
3.8.3 2024 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier 3
4 Point-of-Care Testing (POCT) Market by Type
4.1 Point-of-Care Testing (POCT) Type Introduction
4.1.1 Blood Glucose Testing
4.1.2 Infectious Diseases Testing
4.1.3 Cardiac Markers Testing
4.1.4 Coagulation Testing
4.1.5 Pregnancy and Fertility Testing
4.1.6 Blood Gas/Electrolytes Testing
4.1.7 Urinalysis Testing
4.2 Global Point-of-Care Testing (POCT) Sales by Type
4.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Point-of-Care Testing (POCT) Sales by Type (2020-2031)
4.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2020-2031)
4.3 Global Point-of-Care Testing (POCT) Revenue by Type
4.3.1 Global Point-of-Care Testing (POCT) Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Point-of-Care Testing (POCT) Revenue by Type (2020-2031)
4.3.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2020-2031)
5 Point-of-Care Testing (POCT) Market by Application
5.1 Point-of-Care Testing (POCT) Application Introduction
5.1.1 Clinics
5.1.2 Hospitals
5.1.3 Laboratory
5.1.4 Others
5.2 Global Point-of-Care Testing (POCT) Sales by Application
5.2.1 Global Point-of-Care Testing (POCT) Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Point-of-Care Testing (POCT) Sales by Application (2020-2031)
5.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2020-2031)
5.3 Global Point-of-Care Testing (POCT) Revenue by Application
5.3.1 Global Point-of-Care Testing (POCT) Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Point-of-Care Testing (POCT) Revenue by Application (2020-2031)
5.3.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2020-2031)
6 Global Point-of-Care Testing (POCT) Sales by Region
6.1 Global Point-of-Care Testing (POCT) Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Point-of-Care Testing (POCT) Sales by Region (2020-2031)
6.2.1 Global Point-of-Care Testing (POCT) Sales by Region (2020-2025)
6.2.2 Global Point-of-Care Testing (POCT) Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Point-of-Care Testing (POCT) Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Point-of-Care Testing (POCT) Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Point-of-Care Testing (POCT) Revenue by Region
7.1 Global Point-of-Care Testing (POCT) Revenue by Region
7.1.1 Global Point-of-Care Testing (POCT) Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Point-of-Care Testing (POCT) Revenue by Region (2020-2025)
7.1.3 Global Point-of-Care Testing (POCT) Revenue by Region (2026-2031)
7.1.4 Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Point-of-Care Testing (POCT) Revenue (2020-2031)
7.2.2 North America Point-of-Care Testing (POCT) Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Point-of-Care Testing (POCT) Revenue (2020-2031)
7.3.2 Europe Point-of-Care Testing (POCT) Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Point-of-Care Testing (POCT) Revenue (2020-2031)
7.4.2 Asia-Pacific Point-of-Care Testing (POCT) Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Point-of-Care Testing (POCT) Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Point-of-Care Testing (POCT) Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
8.1.5 Roche Recent Developments
8.2 Abbott
8.2.1 Abbott Comapny Information
8.2.2 Abbott Business Overview
8.2.3 Abbott Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
8.2.5 Abbott Recent Developments
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Comapny Information
8.3.2 Johnson & Johnson Business Overview
8.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
8.3.5 Johnson & Johnson Recent Developments
8.4 Siemens Healthcare
8.4.1 Siemens Healthcare Comapny Information
8.4.2 Siemens Healthcare Business Overview
8.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
8.4.5 Siemens Healthcare Recent Developments
8.5 Danaher
8.5.1 Danaher Comapny Information
8.5.2 Danaher Business Overview
8.5.3 Danaher Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
8.5.5 Danaher Recent Developments
8.6 Ascensia
8.6.1 Ascensia Comapny Information
8.6.2 Ascensia Business Overview
8.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
8.6.5 Ascensia Recent Developments
8.7 Bio-Rad Laboratories
8.7.1 Bio-Rad Laboratories Comapny Information
8.7.2 Bio-Rad Laboratories Business Overview
8.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
8.7.5 Bio-Rad Laboratories Recent Developments
8.8 BioMerieux
8.8.1 BioMerieux Comapny Information
8.8.2 BioMerieux Business Overview
8.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
8.8.5 BioMerieux Recent Developments
8.9 ARKRAY
8.9.1 ARKRAY Comapny Information
8.9.2 ARKRAY Business Overview
8.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
8.9.5 ARKRAY Recent Developments
8.10 Nova Biomedical
8.10.1 Nova Biomedical Comapny Information
8.10.2 Nova Biomedical Business Overview
8.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
8.10.5 Nova Biomedical Recent Developments
8.11 Trividia Health
8.11.1 Trividia Health Comapny Information
8.11.2 Trividia Health Business Overview
8.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
8.11.5 Trividia Health Recent Developments
8.12 Quidel
8.12.1 Quidel Comapny Information
8.12.2 Quidel Business Overview
8.12.3 Quidel Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
8.12.5 Quidel Recent Developments
8.13 Accriva
8.13.1 Accriva Comapny Information
8.13.2 Accriva Business Overview
8.13.3 Accriva Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
8.13.5 Accriva Recent Developments
8.14 OraSure Technologies
8.14.1 OraSure Technologies Comapny Information
8.14.2 OraSure Technologies Business Overview
8.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
8.14.5 OraSure Technologies Recent Developments
8.15 Helena Laboratories
8.15.1 Helena Laboratories Comapny Information
8.15.2 Helena Laboratories Business Overview
8.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
8.15.5 Helena Laboratories Recent Developments
8.16 A. Menarini Diagnostics
8.16.1 A. Menarini Diagnostics Comapny Information
8.16.2 A. Menarini Diagnostics Business Overview
8.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.16.5 A. Menarini Diagnostics Recent Developments
8.17 Abaxis (Zoetis)
8.17.1 Abaxis (Zoetis) Comapny Information
8.17.2 Abaxis (Zoetis) Business Overview
8.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
8.17.5 Abaxis (Zoetis) Recent Developments
8.18 Ortho Clinical Diagnostics
8.18.1 Ortho Clinical Diagnostics Comapny Information
8.18.2 Ortho Clinical Diagnostics Business Overview
8.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.18.5 Ortho Clinical Diagnostics Recent Developments
8.19 Phamatech
8.19.1 Phamatech Comapny Information
8.19.2 Phamatech Business Overview
8.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
8.19.5 Phamatech Recent Developments
8.20 Chembio Diagnostics
8.20.1 Chembio Diagnostics Comapny Information
8.20.2 Chembio Diagnostics Business Overview
8.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.20.5 Chembio Diagnostics Recent Developments
8.21 Trinity Biotech
8.21.1 Trinity Biotech Comapny Information
8.21.2 Trinity Biotech Business Overview
8.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
8.21.5 Trinity Biotech Recent Developments
8.22 ELITech Group
8.22.1 ELITech Group Comapny Information
8.22.2 ELITech Group Business Overview
8.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
8.22.5 ELITech Group Recent Developments
8.23 Response Biomedical
8.23.1 Response Biomedical Comapny Information
8.23.2 Response Biomedical Business Overview
8.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
8.23.5 Response Biomedical Recent Developments
8.24 Princeton BioMeditech
8.24.1 Princeton BioMeditech Comapny Information
8.24.2 Princeton BioMeditech Business Overview
8.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
8.24.5 Princeton BioMeditech Recent Developments
8.25 Alfa Wassermann
8.25.1 Alfa Wassermann Comapny Information
8.25.2 Alfa Wassermann Business Overview
8.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2020-2025)
8.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
8.25.5 Alfa Wassermann Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Point-of-Care Testing (POCT) Value Chain Analysis
9.1.1 Point-of-Care Testing (POCT) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Point-of-Care Testing (POCT) Production Mode & Process
9.2 Point-of-Care Testing (POCT) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Point-of-Care Testing (POCT) Distributors
9.2.3 Point-of-Care Testing (POCT) Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings